Constitutional issues in the use of pharmacogenomic variations associated with race.
Robertson, John A.
In: Rothstein, Mark A., ed. Pharmacogenomics: Social, Ethical, and Clinical Dimensions. Hoboken, N.J.: Wiley-Liss; 2003: 291-316.
Showing items related by title, author, creator and subject.
Robertson, John A. (2006)
Gay, David; Lynxwiler, John (1999-07)
Notifying Patients Exposed to Blood Products Associated With Creutzfeldt-Jakob Disease: Integrating Science, Legal Duties and Ethical Mandates Caulfield, Timothy; Dossetor, John; Boshkov, Lynn; Hannon, Judith; Sawyer, Douglas; Robertson, Gerald (1997-11-15)The issue of notifying people who have been exposed to blood products that have been associated with Creutzfeldt-Jakob disease (CJD) has arisen at a time when the Canadian blood system is under intense scrutiny. As a ...